Immunovant Inc (IMVT) Ownership

$31.77

$0.75 (-2.31%)
Last update: 05:11 PM EST
Day's range
$31.62
Day's range
$32.77

Immunovant Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/10/2026 15.70 M $530.49 M   -2.98% 7.64%
DEEP TRACK CAPITAL, LP 11/16/2026 9.16 M $309.45 M   -1.93% 4.46%
BLACKROCK, INC. 11/13/2026 7.43 M $250.84 M   3.41% 3.61%
FARALLON CAPITAL MANAGEMENT, L.L.C. 11/16/2026 6.47 M $218.59 M   11.47% 3.15%
MORGAN STANLEY 11/13/2026 5.68 M $192.03 M   25.36% 2.77%
TWO SEAS CAPITAL LP 10/06/2026 4.61 M $155.82 M   46.50% 2.24%
TCG CROSSOVER MANAGEMENT, LLC 11/16/2026 4.46 M $150.59 M   0.00% 2.17%
VANGUARD PORTFOLIO MANAGEMENT LLC 11/13/2026 4.26 M $144.06 M   9.06% 2.07%
STATE STREET CORP 11/12/2026 4.20 M $141.76 M   -9.11% 2.04%
VANGUARD CAPITAL MANAGEMENT LLC 11/13/2026 4.09 M $138.07 M   12.33% 1.99%
RTW INVESTMENTS, LP 11/16/2026 3.18 M $107.35 M   0.00% 1.55%
JENNISON ASSOCIATES LLC 11/16/2026 2.92 M $98.50 M   -11.91% 1.42%
BAKER BROS. ADVISORS LP 11/16/2026 2.77 M $93.58 M   -49.03% 1.35%
GEODE CAPITAL MANAGEMENT, LLC 11/06/2026 2.25 M $76.00 M   0.66% 1.09%
ADAR1 CAPITAL MANAGEMENT, LLC 11/16/2026 2.12 M $71.46 M   -9.23% 1.03%
WOODLINE PARTNERS LP 11/16/2026 1.98 M $66.74 M   0.00% 0.96%
PRICE T ROWE ASSOCIATES INC /MD/ 11/16/2026 1.81 M $61.00 M   -1.29% 0.88%
ARMISTICE CAPITAL, LLC 11/16/2026 1.74 M $58.72 M   0.12% 0.85%
ARMISTICE CAPITAL, LLC 11/16/2026 1.63 M $54.89 M   35.42% 0.79%
GOLDMAN SACHS GROUP INC 11/16/2026 1.60 M $54.12 M   -8.51% 0.78%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/16/2026 1.47 M $49.78 M   -33.69% 0.72%
ALPINE GLOBAL MANAGEMENT, LLC 11/16/2026 1.37 M $46.26 M   -0.40% 0.67%
BANK OF AMERICA CORP /DE/ 11/16/2026 1.35 M $45.66 M   14.40% 0.66%
D. E. SHAW & CO., INC. 11/16/2026 1.11 M $37.42 M   -10.71% 0.54%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/16/2026 1.02 M $34.56 M   50.34% 0.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 999.56 K $33.76 M   -2.25% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 968.60 K $32.72 M   429.29% 0.47%
ABERDEEN GROUP PLC 11/10/2026 879.33 K $29.70 M   2.60% 0.43%
NATIXIS 11/06/2026 830.00 K $28.04 M   100.00% 0.40%
NORTHERN TRUST CORP 11/16/2026 795.32 K $26.87 M   0.17% 0.39%
RENAISSANCE TECHNOLOGIES LLC 11/12/2026 779.50 K $26.33 M   7.25% 0.38%
UBS GROUP AG 11/10/2026 742.89 K $25.09 M   57.35% 0.36%
BANK OF NEW YORK MELLON CORP 11/05/2026 655.45 K $22.14 M   121.59% 0.32%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2026 624.06 K $21.08 M   0.80% 0.30%
VANGUARD FIDUCIARY TRUST CO 11/13/2026 590.40 K $19.94 M   4.64% 0.29%
FISHER ASSET MANAGEMENT, LLC 11/06/2026 545.73 K $18.43 M   100.00% 0.27%
PERCEPTIVE ADVISORS LLC 11/16/2026 519.35 K $17.54 M   -61.74% 0.25%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/10/2026 417.50 K $14.10 M   -11.92% 0.20%
JUMP FINANCIAL, LLC 11/13/2026 368.85 K $12.46 M   195.11% 0.18%
PICTET ASSET MANAGEMENT HOLDING SA 11/03/2026 359.08 K $12.13 M   -22.34% 0.17%
BNP PARIBAS FINANCIAL MARKETS 11/12/2026 357.13 K $12.06 M   11.58% 0.17%
MARSHALL WACE, LLP 11/13/2026 343.34 K $11.60 M   140.96% 0.17%
NUVEEN, LLC 11/10/2026 288.03 K $9.73 M   -52.16% 0.14%
TETRAGON PARTNERS GP LTD 11/16/2026 275.22 K $9.30 M   7.54% 0.13%
MILLENNIUM MANAGEMENT LLC 11/16/2026 256.79 K $8.67 M   -21.87% 0.12%
JANE STREET GROUP, LLC 11/12/2026 253.70 K $8.57 M   -18.27% 0.12%
SQUAREPOINT OPS LLC 11/09/2026 245.49 K $8.29 M   215.67% 0.12%
SUPERSTRING CAPITAL MANAGEMENT LP 11/16/2026 222.12 K $7.50 M   6.60% 0.11%
QUBE RESEARCH & TECHNOLOGIES LTD 11/13/2026 219.52 K $7.42 M   100.00% 0.11%
HIGHVISTA STRATEGIES LLC 11/13/2026 205.95 K $6.96 M   -25.88% 0.10%

Immunovant Inc institutional Ownership - FAQ's

During the previous two years, 303 institutional investors and hedge funds held shares of Immunovant Inc. The most heavily invested institutionals were:

FMR LLC: 15.7 M

Deep Track Capital, LP: 9.16 M

BlackRock, Inc.: 7.43 M

FARALLON CAPITAL MANAGEMENT, L.L.C.: 6.47 M

MORGAN STANLEY: 5.68 M

Two Seas Capital LP: 4.61 M

53.03% of Immunovant Inc stock is owned by institutional investors.

Institutional investors have bought a total of 127.09 M shares in the last 24 months. This purchase volume represents approximately $4.04 B in transactions.